Dr. Frank Torti, the FDA's science chief, is set to become its acting commissioner. President-elect Barack Obama and his transition team could announce a permanent
appointee to lead the FDA in the next three weeks, sources said. Wall Street Journal, (subscription required) (01/12)
Tuesday, January 13, 2009
More FDA Changes: New Acting Commissioner, more allegations
WSJ: The new Acting Commissioner is Food and Drug Administration Chief Scientist Frank Torti.
William Gimson III, chief operating officer at the CDC, will serve as acting director after Dr. Julie Gerberding leaves the agency Jan. 20.
Torti will have his hands full right away - nine device scientists report being pressured to approve unsafe and ineffective products. In the letter, the scientists described an agency where President Bush's FDA managers "ordered, intimidated and coerced scientists to manipulate their research results in violation of federal law."